These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins. Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R. J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684 [Abstract] [Full Text] [Related]
23. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics. Jones RN, Barry AL. Rev Infect Dis; 1983 Apr; 5 Suppl 1():S108-26. PubMed ID: 6221381 [Abstract] [Full Text] [Related]
28. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams. Neu HC. Curr Clin Top Infect Dis; 1987 Apr; 8():37-61. PubMed ID: 3077281 [Abstract] [Full Text] [Related]
39. In vitro investigation of BK-218, a new oral and parenteral cephalosporin. Szabó I, Barabás J, Tar A, Kiss L, Filep M, Schmidt T, Marossy K, Tóth-Martinez B, Barabás G, Hernádi F. Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582 [Abstract] [Full Text] [Related]